# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $7 price target.
Absci (NASDAQ:ABSI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10...
Today, Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, announced a collaboration with Memori...
Keybanc analyst Scott Schoenhaus maintains Absci (NASDAQ:ABSI) with a Overweight and lowers the price target from $8 to $6.
Morgan Stanley analyst Vikram Purohit initiates coverage on Absci (NASDAQ:ABSI) with a Overweight rating and announces Price...
On Monday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc. (NASDAQ:COIN) taking the spotligh...